Russell Investments Group Ltd. Has $5.28 Million Position in ICU Medical, Incorporated (ICUI)

Russell Investments Group Ltd. raised its holdings in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 32.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 20,919 shares of the medical instruments supplier’s stock after purchasing an additional 5,132 shares during the period. Russell Investments Group Ltd. owned approximately 0.10% of ICU Medical worth $5,280,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Hsbc Holdings PLC boosted its stake in ICU Medical by 72.1% during the 1st quarter. Hsbc Holdings PLC now owns 3,934 shares of the medical instruments supplier’s stock valued at $993,000 after purchasing an additional 1,648 shares during the last quarter. Evergreen Capital Management LLC purchased a new stake in ICU Medical during the 1st quarter valued at $411,000. New York State Common Retirement Fund boosted its stake in ICU Medical by 7.0% during the 1st quarter. New York State Common Retirement Fund now owns 75,172 shares of the medical instruments supplier’s stock valued at $18,973,000 after purchasing an additional 4,903 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in ICU Medical by 6.8% during the 1st quarter. JPMorgan Chase & Co. now owns 472,988 shares of the medical instruments supplier’s stock valued at $119,382,000 after purchasing an additional 29,977 shares during the last quarter. Finally, Brinker Capital Inc. boosted its stake in ICU Medical by 2.6% during the 1st quarter. Brinker Capital Inc. now owns 8,097 shares of the medical instruments supplier’s stock valued at $2,044,000 after purchasing an additional 205 shares during the last quarter. Institutional investors and hedge funds own 72.22% of the company’s stock.

Several brokerages have commented on ICUI. ValuEngine upgraded ICU Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 2nd. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “strong-buy” rating and set a $311.00 target price on the stock in a research note on Wednesday, May 16th. TheStreet downgraded ICU Medical from an “a” rating to a “c+” rating in a research note on Wednesday, May 9th. Finally, BidaskClub upgraded ICU Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, April 28th. One equities research analyst has rated the stock with a buy rating and three have given a strong buy rating to the company. The company presently has an average rating of “Strong Buy” and an average target price of $311.00.

In other news, VP Alison D. Burcar sold 77,227 shares of the firm’s stock in a transaction on Wednesday, June 20th. The stock was sold at an average price of $302.00, for a total value of $23,322,554.00. Following the transaction, the vice president now directly owns 21,311 shares in the company, valued at approximately $6,435,922. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Virginia Ruth Sanzone sold 500 shares of the firm’s stock in a transaction on Tuesday, May 15th. The stock was sold at an average price of $269.85, for a total value of $134,925.00. Following the completion of the transaction, the vice president now owns 617 shares in the company, valued at $166,497.45. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 226,341 shares of company stock worth $64,095,270. Company insiders own 12.50% of the company’s stock.

ICU Medical opened at $288.60 on Thursday, MarketBeat Ratings reports. The firm has a market capitalization of $6.06 billion, a PE ratio of 56.37 and a beta of 0.36. ICU Medical, Incorporated has a 1 year low of $164.00 and a 1 year high of $313.20.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Wednesday, May 9th. The medical instruments supplier reported $2.26 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.84 by $0.42. The firm had revenue of $372.00 million for the quarter, compared to the consensus estimate of $346.28 million. ICU Medical had a return on equity of 9.55% and a net margin of 1.25%. The company’s revenue for the quarter was up 50.2% on a year-over-year basis. During the same period last year, the business posted $1.68 EPS. research analysts predict that ICU Medical, Incorporated will post 6.66 earnings per share for the current year.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply